ALPHARETTA, Ga., Feb. 11, 2014 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that it has signed an agreement with Wirthlin, a Dentons Innovation Group Partnership (Wirthlin-Dentons), to provide strategic advisory services and to establish a joint venture company that will license its dermaPACE® device and create a sales and distribution system for the GCC – defined as the Kingdom of Saudi Arabia, United Arab Emirates, Kuwait, Qatar, and Bahrain. The joint venture arrangement expects to have a legal and organizational structure in place in the second quarter of 2014, which enables rollout of SANUWAVE’s dermaPACE device in the fourth quarter.
Help employers find you! Check out all the jobs and post your resume.
